α1‐Antitrypsin Z allele and risk of venous thromboembolism in the general population

Abboud, 2011, Alpha1‐antitrypsin deficiency: a clinical‐genetic overview, Appl Clini Genet, 4, 55, 10.2147/TACG.S10604 Gooptu, 2014, The molecular and cellular pathology of alpha(1)‐antitrypsin deficiency, Trends Mol Medi, 20, 116, 10.1016/j.molmed.2013.10.007 Luisetti, 2004, Alpha1‐antitrypsin deficiency. 1: epidemiology of alpha1‐antitrypsin deficiency, Thorax, 59, 164, 10.1136/thorax.2003.006494 Mayer, 2006, Risk factors for symptom onset in PI*Z alpha‐1 antitrypsin deficiency, Int J Chronic Obstruct Pulm Dis, 1, 485 Heck, 1974, Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1‐antitrypsin, J Exp Med, 140, 1615, 10.1084/jem.140.6.1615 Walsh, 1987, Regulation of factor XIa activity by platelets and alpha 1‐protease inhibitor, J Clin Invest, 80, 1578, 10.1172/JCI113244 Gans, 1967, Alpha‐1‐antitrypsin, an inhibitor for thrombin and plasmin, Clin Chim Acta, 17, 111, 10.1016/0009-8981(67)90104-0 Matheson, 1976, Inactivation of human thrombin in the presence of human alpha1‐proteinase inhibitor, Biochem J, 159, 495, 10.1042/bj1590495 Clemmensen, 1976, Inhibition of urokinase by complex formation with human alpha1‐antitrypsin, Biochim Biophys Acta, 429, 591, 10.1016/0005-2744(76)90307-7 Heeb, 1988, Physiologic inhibition of human activated protein C by alpha 1‐antitrypsin, J Biol Chem, 263, 11613, 10.1016/S0021-9258(18)37825-6 Gupta, 2014, A rare case of alpha 1‐antitrypsin deficiency associated with hypogammaglobulinemia and recurrent pulmonary thrombosis, Anna Thoracic Med, 9, 39, 10.4103/1817-1737.124442 Milger, 2015, Identification of a novel SERPINA‐1 mutation causing alpha‐1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism, Int J Chronic Obstruct Pulm Dis, 10, 891, 10.2147/COPD.S80173 Basil, 2021, Severe alpha‐1‐antitrypsin deficiency increases the risk of venous thromboembolism, J Thromb Haemost, 19, 1519, 10.1111/jth.15302 Ingebrigtsen, 2015, Fibrinogen and alpha1‐antitrypsin in COPD exacerbations, Thorax, 70, 1014, 10.1136/thoraxjnl-2015-207561 The Copenhagen General Population Study. Available from: http://www.cgps.dk. Pedersen, 2011, The Danish civil registration system, Scand J Public Health, 39, 22, 10.1177/1403494810387965 Helweg‐Larsen, 2011, The Danish register of causes of death, Scand J Public Health, 39, 26, 10.1177/1403494811399958 Lynge, 2011, The Danish national patient register, Scand J Public Health, 39, 30, 10.1177/1403494811401482 Colak, 2015, Characteristics and prognosis of never‐smokers and smokers with asthma in the Copenhagen general population study. A prospective cohort study, Am J Respir Crit Care Med, 192, 172, 10.1164/rccm.201502-0302OC Wei, 1989, Regression analysis of multivariate incomplete failure time data by modeling marginal distributions, J Am Stat Assoc, 84, 1065, 10.1080/01621459.1989.10478873 Andersen, 1982, Cox's regression model for counting processes: a large sample study, Anna Stat, 10, 1100 Altman, 2011, How to obtain the confidence interval from a P value, BMJ, 343, d2090, 10.1136/bmj.d2090 Newson, 2013, Attributable and unattributable risks and fractions and other scenario comparisons, Stata J, 13, 672, 10.1177/1536867X1301300402 Tanash, 2016, Cause‐specific mortality in individuals with severe alpha 1‐antitrypsin deficiency in comparison with the general population in Sweden, Int J Chronic Obstruct Pulm Dis, 11, 1663, 10.2147/COPD.S109173 Lindström, 2019, Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism, Blood, 134, 1645, 10.1182/blood.2019000435 Klarin, 2019, Genome‐wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease, Nat Genet, 51, 1574, 10.1038/s41588-019-0519-3 Sundbøll, 2016, Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study, BMJ Open, 6, 10.1136/bmjopen-2016-012832